missing translation for 'onlineSavingsMsg'
Få mere at vide
Få mere at vide
Meloxicam 1.0 mg/ml in Dimethyl Sulfoxide, LoGiCal
Beskrivelse
Meloxicam 1.0 mg/ml in Dimethyl Sulfoxide
Tekniske data
Tekniske data
| Kemisk navn eller materiale | Meloxicam |
| CAS | 71125-38-7 |
| Analyt- eller komponentnavne | Meloxicam |
| Forsendelsestilstand | Room Temperature |
| Molekylær formel | C14 H13 N3 O4 S2 |
| Certificeringer/compliance | ISO 17034 |
| Synonym | 2 H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide, Coxflam, Maxicam, Melonex, Meloxicam, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2 H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2 H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2 H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2 H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2 H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2 H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2 H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2 H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2 H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide |
| InChI formel | InChI=1 S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18 H,1-2H3,(H,15,16,19) |
| SMIL | CN1C(=C(O)c2ccccc2S1(=O)=O)C(=O)Nc3ncc(C)s3 |
| IUPAC navn | 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1λ^{6},2-benzothiazine-3-carboxamide |
| Vis mere |
Produkttitel
Ved at klikke på Send, anerkender du, at du kan blive kontaktet af Fisher Scientific med hensyn til den feedback, du har givet i denne formular. Vi deler ikke dine oplysninger til andre formål. Alle angivne kontaktoplysninger skal også vedligeholdes i overensstemmelse med vores Privatlivspolitik.
Ser du en mulighed for forbedring?